erythrokeratodermia-cardiomyopathy syndrome
ORPHA: 4760961 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| metoprolol | oral tablet 25mg, 50mg, 100mg; extended-release tablet; IV injection | FDA Approved | 9 | 2d |
Classification & Codes
Orphanet Code
ORPHA:476096erythrokeratodermia-cardiomyopathy syndrome
| Orphanet | ORPHA:476096 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO